About Kristi Jones
Kristi Jones is the CEO with over 25 years of experience in the biotechnology and pharmaceutical industries, having held leadership roles at NexImmune, AstraZeneca, MedImmune, and Genentech.
Known information
Kristi Jones currently serves as the Chief Executive Officer, bringing over 25 years of extensive leadership experience in the biotechnology and pharmaceutical sectors. She has previously held multiple positions on the executive team at NexImmune, including roles as Chief Operating Officer and Chief Business Officer. Prior to her tenure at NexImmune, Kristi worked at AstraZeneca and its subsidiary MedImmune for five years, where she was Vice President of Portfolio Strategy and Management from 2013 to 2015 and Vice President of Global Strategic Marketing at MedImmune. Her career also includes a significant 16-year period at Genentech, where she held various leadership roles, notably as Head of Immunology and Ophthalmology in Global Portfolio and Product Strategy. Beyond her corporate roles, Kristi actively serves in a consulting capacity for various companies and organizations. She is also a member of the Life Science Panel for Springboard Enterprises, which focuses on supporting start-up companies led by women.
About NexImmune
NexImmune is a biotechnology company that develops innovative technologies to direct cell-mediated immune responses for treating a variety of diseases, including cancer, infectious, and autoimmune diseases.